Dr. Suneet Agarwal is Associate Professor of Pediatrics at Harvard Medical School and Co-Program Leader for the Stem Cell Transplant (SCT) Center at Dana-Farber / Boston Children’s Cancer and Blood Disorders Center, and a Principal Faculty member of the Harvard Stem Cell Institute and Harvard Initiative in RNA Medicine. Dr. Agarwal completed his Sc.B in Biochemistry at Brown University followed by M.D. and Ph.D. training (Immunology) at Harvard Medical School. He undertook pediatrics residency training in the Boston Combined Residency Program, followed by a fellowship in hematology/oncology at Boston Children's Hospital /Dana-Farber Cancer Institute, where he served as Chief Fellow. He conducted postdoctoral research with Dr. George Daley in stem cell biology at Boston Children's Hospital. Dr. Agarwal's current research efforts at Boston Children's Hospital are centered around rare genetic blood diseases, with an emphasis on impaired hematopoiesis. His research lab investigates basic mechanisms of telomere and mitochondrial biology and associated human disorders, with active efforts to develop first-in-class small molecule therapeutics. He is also principal investigator of an international multi-center stem cell transplant trial for bone marrow failure disorders associated with short telomeres, which aims to achieve myeloid engraftment without exposure to radiation or alkylating agents for the first time. In addition to his research, Dr. Agarwal serves as attending physician on the SCT service at Boston Children's Hospital, course director in the Harvard/MIT Health Sciences and Technology program, member of the Executive Admissions Committee of the Harvard/MIT MD/PHD program, and chair of the Medical Advisory Board of the patient advocacy group Team Telomere.